EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Anti‐Inflammatory Bowel Disease Activity of Pterostilbene Derivatives

Xingxing Zhang, Bin Li, Xiaohan Liu, Liuzeng Chen, Banfeng Ruan iD, Chun Xia iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202401081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Xingxing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, Food and Environment, Hefei University, Hefei, 230601, P. R. China. Hauptthemen laut MEDLINE: Stilbenes, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Scientific Research Foundation for Advanced Talents of Hefei University, Natural Science Foundation of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aberrant activation of NLRP3 inflammasomes is intricately linked to various inflammatory diseases. In this study, we present the discovery and optimization of a series of NLRP3 inflammasome inhibitors based on the pterostilbene skeleton. All compounds underwent screening to evaluate their inhibitory effects on LPS/Nigericin‐induced IL‐1β secretion and anti‐cellular pyroptosis. Most compounds exhibit good biological activity and cellular safety, with compound D20 showing the most prominent activity. Preliminary mechanism studies suggest that compound D20 may affect the assembly of NLRP3 inflammasomes by targeting the NLRP3 protein, thereby inhibiting the activation of NLRP3 inflammasomes. The in vivo anti‐inflammatory activity demonstrated significant therapeutic effect of compound D20 on DSS‐induced acute colitis model in mice. This work has important reference significance for the development of drugs targeting NLRP3 inflammasomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StilbenesNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesAnimalsMiceHumansInflammatory Bowel DiseasesDextran SulfateAnti-Inflammatory AgentsStructure-Activity RelationshipInterleukin-1betaMolecular StructureMice, Inbred C57BLLipopolysaccharidesColitisDisease Models, AnimalDose-Response Relationship, DrugPyroptosis

Stichwörter der Autor:innen

IBDInflammationInhibitorPterostilbene derivatives

Substanzen

pterostilbeneStilbenesNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesDextran SulfateAnti-Inflammatory AgentsInterleukin-1betaLipopolysaccharides

Autor:innen und Institutionen

  • School of Biology, Food and Environment, Hefei University, Hefei, 230601, P. R. China.
  • Institute of Advanced Technology, University of Science and Technology of China, Hefei, 230000, P. R. China.
  • Luzhou Branch of Sichuan Tobacco Company, Luzhou, 646000, P. R. China.

ORCID-Profile: Banfeng Ruan, Chun Xia

Förderung

  • Scientific Research Foundation for Advanced Talents of Hefei University
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Zhang, X., Li, B., Liu, X., Chen, L., Ruan, B., & Xia, C. (2024). Synthesis and Anti‐Inflammatory Bowel Disease Activity of Pterostilbene Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401081

Vancouver

Zhang X, Li B, Liu X, Chen L, Ruan B, Xia C. Synthesis and Anti‐Inflammatory Bowel Disease Activity of Pterostilbene Derivatives. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401081

BibTeX
@article{Zhang2024,
  author = {Zhang, Xingxing and Li, Bin and Liu, Xiaohan and Chen, Liuzeng and Ruan, Banfeng and Xia, Chun},
  title = {Synthesis and Anti‐Inflammatory Bowel Disease Activity of Pterostilbene Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202401081}
}
Kostenlos starten →